Literature DB >> 17700279

MR-relaxometry of myocardial tissue: significant elevation of T1 and T2 relaxation times in cardiac amyloidosis.

Waldemar Hosch1, Michael Bock, Martin Libicher, Sebastian Ley, Ute Hegenbart, Thomas J Dengler, Hugo A Katus, Hans-Ulrich Kauczor, Günter W Kauffmann, Arnt V Kristen.   

Abstract

OBJECTIVE: This study evaluates if MR-relaxometry of myocardial tissue reveals significant differences in cardiac amyloidosis (CA) compared with patients with systemic amyloidosis but without cardiac involvement (NCA) and a healthy control group. Therefore, we measured T1 and T2 relaxation times (RT) of the left ventricular myocardium with magnetic resonance imaging at 1.5 T.
MATERIAL AND METHODS: Nineteen consecutive patients (14 males, 5 females; mean age, 59 +/- 6.1 years) with histologically proven CA were evaluated. T1-RT and T2-RT were measured by using a saturation-recovery TurboFLASH sequence and a HASTE sequence, respectively. Additionally, morphologic and functional data were acquired. Results were compared with patients with systemic amyloidosis but without cardiac involvement (NCA; 5 males, 4 females, 48.9 +/- 15.4 years) and 10 healthy, age-matched control subjects (5 males, 5 females, 60.4 +/- 6.4 years).
RESULTS: MR-relaxometry revealed a significant elevation of T1-RT of the left ventricular myocardium in CA-patients compared with that in NCA-patients and the age-matched control group [mean +/- SD (95% CI) 1340 +/- 81 (1303-1376) msec, 1213 +/- 79 (1160-1266) msec, 1146 +/- 71 (1096-1196) msec, respectively; CA vs. control, P < 0.0001; CA vs. NCA:, P < 0.0003; NCA vs. control, P = 0.07]. T2-RT showed a marginal but significant increase in CA-patients compared with NCA-patients and the control group [mean +/- SD (95% CI) 81 +/- 12 (76-86) msec, 71 +/- 11 (64-79) msec, 72 +/- 9 (65-79) msec, respectively; CA vs. control, P = 0.04; CA vs. NCA, P = 0.04; NCA vs. control, P = 0.91]. T1-RT was best suited to discriminate between the groups as shown by logistic regression. A cut-off value of >or=1273 milliseconds for T1-RT was defined using receiver-operator characteristics-analysis to establish the diagnosis of CA with a high sensitivity (84%) and specificity (>89%).
CONCLUSIONS: Measurement of T1 and T2 RT is a novel approach for noninvasive evaluation of CA. MR-relaxometry might improve diagnostic reliability of magnetic resonance imaging for evaluation of cardiac involvement in systemic amyloidosis.

Entities:  

Mesh:

Year:  2007        PMID: 17700279     DOI: 10.1097/RLI.0b013e318059e021

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  22 in total

1.  MR relaxometry of the liver: significant elevation of T1 relaxation time in patients with liver cirrhosis.

Authors:  Tobias Heye; Schu-Ren Yang; Michael Bock; Sylvia Brost; Kilian Weigand; Thomas Longerich; Hans-Ulrich Kauczor; Waldemar Hosch
Journal:  Eur Radiol       Date:  2012-02-03       Impact factor: 5.315

2.  MRI differentiation of cardiomyopathy showing left ventricular hypertrophy and heart failure: differentiation between cardiac amyloidosis, hypertrophic cardiomyopathy, and hypertensive heart disease.

Authors:  Minako Takeda; Yasuo Amano; Masaki Tachi; Hitomi Tani; Kyoichi Mizuno; Shinichiro Kumita
Journal:  Jpn J Radiol       Date:  2013-08-31       Impact factor: 2.374

Review 3.  Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies.

Authors:  Maythem Saeed; Steven W Hetts; Robert Jablonowski; Mark W Wilson
Journal:  World J Cardiol       Date:  2014-11-26

4.  Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis.

Authors:  Ralf Wassmuth; Hassan Abdel-Aty; Steffen Bohl; Jeanette Schulz-Menger
Journal:  Eur Radiol       Date:  2011-03-29       Impact factor: 5.315

Review 5.  PET/MR: Yet another Tesla?

Authors:  Markus Schwaiger; Karl Kunze; Christoph Rischpler; Stephan G Nekolla
Journal:  J Nucl Cardiol       Date:  2016-09-22       Impact factor: 5.952

6.  Myocardial T1 mapping: techniques and potential applications.

Authors:  Jeremy R Burt; Stefan L Zimmerman; Ihab R Kamel; Marc Halushka; David A Bluemke
Journal:  Radiographics       Date:  2014 Mar-Apr       Impact factor: 5.333

Review 7.  Magnetic resonance imaging for characterizing myocardial diseases.

Authors:  Maythem Saeed; Hui Liu; Chang-Hong Liang; Mark W Wilson
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-31       Impact factor: 2.357

Review 8.  [Risk stratification and treatment of cardiac amyloidoses].

Authors:  A V Kristen; S O Schönland; A Remppis; U Hegenbart; P A Schnabel; H A Katus; T J Dengler
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

9.  Parametric dependence of myocardial blood oxygen level dependent, balanced steady-state free-precession imaging at 1.5 T: theory and experiments.

Authors:  Xiangzhi Zhou; Richard Tang; Rachel Klein; Debiao Li; Rohan Dharmakumar
Journal:  Magn Reson Med       Date:  2010-02       Impact factor: 4.668

10.  In vivo, high-frequency three-dimensional cardiac MR elastography: Feasibility in normal volunteers.

Authors:  Arvin Arani; Kevin L Glaser; Shivaram P Arunachalam; Phillip J Rossman; David S Lake; Joshua D Trzasko; Armando Manduca; Kiaran P McGee; Richard L Ehman; Philip A Araoz
Journal:  Magn Reson Med       Date:  2016-01-17       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.